Abstract
Insulin secretion and actions are reduced at the diagnosis of T2D and continue to decline with the progression of the disease, despite which treatment was instituted. This progression towards the inclusion of new therapies suggests that they do not correct all the metabolic and hormonal dysfunctions necessary to prevent beta cell failure. In a previous study (FAPESP- 2009 / 13904-0), we e…